A detailed history of Quest Partners LLC transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Quest Partners LLC holds 3,520 shares of ACAD stock, worth $60,086. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,520
Previous 2,473 42.34%
Holding current value
$60,086
Previous $40.2 Million 34.72%
% of portfolio
0.0%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$15.14 - $19.14 $15,851 - $20,039
1,047 Added 42.34%
3,520 $54.1 Million
Q2 2024

Aug 06, 2024

SELL
$14.62 - $18.42 $98,611 - $124,242
-6,745 Reduced 73.17%
2,473 $40.2 Million
Q1 2024

May 09, 2024

BUY
$17.79 - $30.86 $141,697 - $245,799
7,965 Added 635.67%
9,218 $170 Million
Q4 2023

Feb 09, 2024

BUY
$20.78 - $31.77 $26,037 - $39,807
1,253 New
1,253 $39.2 Million

Others Institutions Holding ACAD

About ACADIA PHARMACEUTICALS INC


  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.76B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Quest Partners LLC Portfolio

Follow Quest Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quest Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quest Partners LLC with notifications on news.